发明名称 |
Glucagon antagonists/inverse agonists |
摘要 |
Novel compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any diseases and disorders, wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism and obesity. |
申请公布号 |
AU2350102(A) |
申请公布日期 |
2002.05.27 |
申请号 |
AU20020023501 |
申请日期 |
2001.11.15 |
申请人 |
NOVO-NORDISK A/S;AGOURON PHARMACEUTICALS, INC. |
发明人 |
PETER MADSEN;JESPER LAU;ANTHONY LING |
分类号 |
A61P3/00;C07C275/26;C07C275/28;C07C275/30;C07C275/34;C07C275/36;C07C275/42;C07C311/47;C07C317/42;C07C323/44;C07D209/48;C07D257/04;C07D263/56;C07D263/57;C07D271/06;C07D277/28;C07D277/48;C07D319/08;C07D319/20;C07D333/36;C07D513/04 |
主分类号 |
A61P3/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|